Food and Microbiome Longitudinal Investigation (FAMiLI)
Launched by NYU LANGONE HEALTH · Sep 22, 2017
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Food and Microbiome Longitudinal Investigation (FAMiLI) is a clinical trial that aims to learn more about how the tiny organisms in our bodies, known as the microbiome, affect our health, especially in conditions like cancer and heart disease. By studying a diverse group of people, researchers hope to uncover important information that could lead to better treatments and understanding of these illnesses.
To participate in this study, you need to be over 40 years old and not currently taking long-term antibiotics or pregnant. If you join, you can expect to share information about your health and possibly provide samples for research. This study is an exciting opportunity to contribute to medical knowledge that could help many people in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 40
- Exclusion Criteria:
- • Use of long term antibiotics.
- • Pregnant
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Jiyoung Ahn, PhD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials